{
    "2021-03-04": [
        [
            {
                "time": "",
                "original_text": "因可转换债券获转换 药明康德(02359)发行22.59万股",
                "features": {
                    "keywords": [
                        "可转换债券",
                        "药明康德",
                        "发行"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "举牌出牛股，平均涨超15%：这些获“内部人”买买买",
                "features": {
                    "keywords": [
                        "举牌",
                        "牛股",
                        "内部人"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】药明康德(02359-HK)跌6.53%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "全球药闻 | 首个出海新药百悦泽?再传捷报；药明康德收购OXGENE；赛生药业港交所上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "收购",
                        "OXGENE",
                        "新药",
                        "百悦泽"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "野村东方国际证券：药明康德(603259.SH)国际化布局再下一城，目标价212元，维持“增持”评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "国际化",
                        "增持",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贵州茅台、中国中免、比亚迪、药明康德等明星股均低开超2%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "明星股",
                        "低开"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "野村国际(香港)--药明康德：进军欧洲，2021年药明康德已在欧洲地区布局2笔收购【公司研究】",
                "features": {
                    "keywords": [
                        "药明康德",
                        "欧洲",
                        "收购",
                        "国际化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}